CTT Pharmaceutical Holdings, Inc.
CTTH
$0.08
-$0.01-6.25%
OTC PK
| 03/31/2026 | 12/31/2025 | 03/31/2025 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | -- | 877.90K | 666.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 877.90K | 666.80K |
| Operating Income | -- | -- | -- | -877.90K | -666.80K |
| Income Before Tax | -- | -- | -- | -1.01M | -674.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -- | -1.01 | -0.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -1.01M | -674.30K |
| EBIT | -- | -- | -- | -877.90K | -666.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -- | -- | -0.05 | -0.03 |
| Normalized Basic EPS | -- | -- | -- | -0.03 | -0.02 |
| EPS Diluted | -- | -- | -- | -0.05 | -0.03 |
| Normalized Diluted EPS | -- | -- | -- | -0.03 | -0.02 |
| Average Basic Shares Outstanding | -- | -- | -- | 69.94M | 65.35M |
| Average Diluted Shares Outstanding | -- | -- | -- | 69.94M | 65.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |